Login / Signup

Abaloparatide dose-dependently increases bone mineral density in postmenopausal women with osteoporosis: a phase 2 study.

Toshio MatsumotoTeruki SoneAkiko YamashitaTetsuo Inoue
Published in: Journal of bone and mineral metabolism (2023)
JapicCTI-132381.
Keyphrases
  • bone mineral density
  • postmenopausal women
  • body composition
  • open label
  • double blind
  • placebo controlled
  • clinical trial